These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1776267)

  • 41. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ampicillin and pentobarbital in the course of subclinical fascioliasis in sheep.
    Tufenkji AE; Alvinerie M; Larrieu G; Houin G; Galtier P
    Res Vet Sci; 1991 Jan; 50(1):75-80. PubMed ID: 2047596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep.
    Delatour P; Benoit E; Garnier F; Besse S
    J Vet Pharmacol Ther; 1990 Dec; 13(4):361-6. PubMed ID: 2287028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of a synthetic diet on the pharmacokinetics of ethyl methyl sulphide and its sulphoxide and sulphone metabolites in rats.
    Nnane LP; Damani LA; Hutt AJ
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):17-24. PubMed ID: 11554429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental ovine fasciolosis: antipyrine clearance as indicator of liver damage.
    Ferre I; López P; Rojo-Vázquez FA; González-Gallego J
    Vet Parasitol; 1996 Mar; 62(1-2):93-100. PubMed ID: 8638398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheep.
    Galtier P; Alvinerie M; Steimer JL; Francheteau P; Plusquellec Y; Houin G
    J Pharm Sci; 1991 Jan; 80(1):3-10. PubMed ID: 2013846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resolution of a disputed albendazole result in the UK Official Control System - time for more guidance?
    Walker M; Gray K; Hopley C; Mussell C; Clifford L; Meinerikandathevan J; Firpo L; Topping J; Santacruz D
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2017 Apr; 34(4):489-493. PubMed ID: 27690756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver sulphoxidative metabolism of albendazole in rat: enantioselectivity and effect of methimazole.
    Solana HD; Sallovitz JM; Najle R; Rodriguez JA; Lanusse CE
    Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):83-8. PubMed ID: 10849890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of triclabendazole in rabbits.
    Alvarez-Bujidos ML; Ortiz AI; Negro A; Cubría JC; Ordóñez D
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Nov; 106(3):805-8. PubMed ID: 7905812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The binding and distribution of albendazole and its principal metabolites in Giardia duodenalis.
    Oxberry ME; Reynoldson JA; Thompson RC
    J Vet Pharmacol Ther; 2000 Jun; 23(3):113-20. PubMed ID: 11110097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of hepatic mitochondrial respiration and microsomal cytochrome P450 content in mice infected with the liver fluke Fasciola hepatica.
    Somerville AC; Bygrave FL; Behm CA
    Int J Parasitol; 1995 Jun; 25(6):667-72. PubMed ID: 7657451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep.
    Elsheikh HA; Ali BH
    J Vet Pharmacol Ther; 1997 Jun; 20(3):167-72. PubMed ID: 9185081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The early history of xenobiotic sulfoxidation.
    Mitchell SC; Waring RH
    Drug Metab Rev; 1985-1986; 16(3):255-84. PubMed ID: 3914937
    [No Abstract]   [Full Text] [Related]  

  • 54. Simultaneous determination of albendazole and its principal metabolites in plasma by normal phase high-performance liquid chromatography.
    Alvinerie M; Galtier P
    J Pharm Biomed Anal; 1984; 2(1):73-9. PubMed ID: 16867767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disposition and metabolism of dipropyl disulphide in vivo in rat.
    Germain E; Semon E; Siess MH; Teyssier C
    Xenobiotica; 2008 Jan; 38(1):87-97. PubMed ID: 18098065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromatographic separation of methionine, methionine sulphoxide, methionine sulphone, and their products of oral microbial metabolism.
    Tonzetich J
    Anal Biochem; 1976 Jun; 73(2):290-300. PubMed ID: 962044
    [No Abstract]   [Full Text] [Related]  

  • 57. Model-independent procedure for area estimation and intergroup comparisons.
    Capizzi T; Mehta H; Oppenheimer L
    J Pharm Sci; 1983 Sep; 72(9):995-9. PubMed ID: 6631712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of the gut flora in the reduction of sulphoxide containing drugs.
    Renwick AG; Strong HA; George CF
    Biochem Pharmacol; 1986 Jan; 35(1):64. PubMed ID: 3940528
    [No Abstract]   [Full Text] [Related]  

  • 59. The distribution of sulphone in the tissues of various animals.
    FRANCIS J
    J Comp Pathol; 1953 Jan; 63(1):1-6. PubMed ID: 13061621
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of an albendazole controlled release capsule on immunity to internal parasites in sheep.
    Williamson JF
    N Z Vet J; 1995 Jun; 43(3):127. PubMed ID: 16031830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.